CME Group (CME)
(Real Time Quote from BATS)
$215.55 USD
-1.22 (-0.56%)
Updated Apr 24, 2024 10:00 AM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CME 215.55 -1.22(-0.56%)
Will CME be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CME based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CME
CME (CME) Reports Q1 Earnings: What Key Metrics Have to Say
Cracking the Code: 5 Reasons a Choppy Market Looms
CME: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What to Expect From CME Group (CME) in Q1 Earnings
Insights Into CME (CME) Q1: Wall Street Projections for Key Metrics
Earnings Preview: Nasdaq (NDAQ) Q1 Earnings Expected to Decline
Other News for CME
CME Group Q1 earnings beat consensus, as clearing and transaction fees rise
CME: Q1 Earnings Snapshot
CME Group Inc. Reports First-Quarter 2024 Financial Results
CME Group Inc (CME) Q1 2024 Earnings: Adjusted EPS Outperforms Estimates
CME Non-GAAP EPS of $2.50 beats by $0.05, revenue of $1.5B beats by $20M